Physician profile
Amanda E Rohn
NPI 1023252301
$2,869.48
in general payments reported to CMS, 2019-2025
34 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $573 · 2020: $76.63 · 2021: $676 · 2022: $457 · 2023: $504 · 2024: $364 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,086.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,086.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $354.94 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Renovia INC | $241.36 | 2019-2021 | |
| Astellas Pharma US INC | $225.74 | 2022-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $225.16 | 2019-2025 | |
| Coopersurgical, INC. | $214.44 | 2019-2024 | Paragard T 380a, Summit Doppler, Endosee |
| Pfizer INC. | $174.62 | 2019-2024 | |
| Therapeuticsmd, INC. | $144.23 | 2019-2022 | |
| Exeltis, USA INC. | $130.94 | 2021-2022 | |
| Thd America, INC. | $120.73 | 2023 | |
| Organon LLC | $98.21 | 2021-2022 | |
| Ethicon US, LLC | $92.01 | 2021-2024 | Ethicon, Vistaseal, Stratafix |
| Mayne Pharma Commercial LLC | $87.33 | 2022-2024 | |
| Aspira Women'S Health INC | $75.09 | 2022-2024 | Ova1 |
| Sumitomo Pharma America, INC. | $66.72 | 2023-2025 | Myfembree |
| Merck Sharp & Dohme LLC | $66.16 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optumhealth Care Solutions, LLC | $63.30 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Avion Pharmaceuticals | $60.72 | 2021-2023 | Balcoltra |
| Molnlycke Health Care US, LLC | $53.61 | 2021 | |
| Sage Therapeutics, LLC | $47.63 | 2021-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $36.18 | 2019 | |
| Millicent US INC | $33.82 | 2019-2023 | Intrarosa, Femring |
| Meditrina | $31.63 | 2024 | |
| Hologic Sales and Service, LLC | $31.17 | 2021-2024 | Novasure, Acessa Provu System, Myosure Tissue Removal Device |
| Duchesnay USA Incorporated | $24.18 | 2019 | |
| Roche Diagnostics Corporation | $24.07 | 2024 | Cobas Liat Analyzer |
| Novum Pharma, LLC | $19.52 | 2019 | |
| Medtronic, INC. | $19.42 | 2024 | V-Loc 180 |
| Amag Pharmaceuticals, INC. | $18.62 | 2020 | |
| Myovant Sciences INC. | $15.52 | 2021 | |
| Ferring Pharmaceuticals INC. | $15.36 | 2019 | |
| Smith+Nephew, INC. | $15.12 | 2022 | |
| Vertical Pharmaceuticals, LLC | $14.93 | 2019 | |
| Minerva Surgical, INC | $14.67 | 2022 | |
| Allergan, INC. | $12.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Rohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.